pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
ALA-002
Social Anxiety Disorder (SAD/Social Phobia)
PharmAla Biotech Inc
0
catalysts
Preclinical
ALC-919
Alzheimer's Disease
Hokkaido University
0
catalysts
Phase 2
ALEP-02
Cervical Cancer
Alentis Therapeutics AG
0
catalysts
ALEVE
ALEVE (NAPROXEN SODIUM)
Bayer AG
catalysts
← prev
page 53 of 271
next →
131
Pain
89
Neurology
1
0
ALFENTA
ALFENTA (ALFENTANIL HYDROCHLORIDE)
Rising Pharma Holdings Inc
0
catalysts
Phase 2
ALG-009
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$ALGS
Aligos Therapeutics, Inc.
0
catalysts
Phase 2
ALG.APV-527
Cervical Cancer
Alligator Bioscience AB
0
catalysts
ALISKIREN
ALISKIREN (ALISKIREN HEMIFUMARATE)
LXO IRELAND
0
catalysts
Preclinical
ALL-027
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Phoenix Nest Inc
0
catalysts
ALLEGRA-D ALLERGY AND CONGESTION
ALLEGRA-D ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)
CHATTEM SANOFI
0
catalysts
ALLERGY CONGESTION RELIEF
ALLERGY CONGESTION RELIEF (LORATADINE, PSEUDOEPHEDRINE SULFATE)
PERRIGO PHARMA INTL
0
catalysts
ALLERGY RELIEF
ALLERGY RELIEF (CETIRIZINE HCL)
ONESOURCE SPECIALTY
0
catalysts
ALLERGY RELIEF-D
ALLERGY RELIEF-D (LORATADINE AND PSEUDOEPHEDRINE SULFATE)
BIONPHARMA
0
catalysts
Phase 1
ALLO-316
Metastatic Renal Cell Carcinoma
$ALLO
Allogene Therapeutics, Inc.
0
catalysts
Phase 1
ALLO-329
Lupus Nephritis
$ALLO
Allogene Therapeutics, Inc.
0
catalysts
pre_registration
ALM-003
Depression
Almatica Pharma LLC
0
catalysts
Phase 1
ALM-412
Dystrophic Epidermolysis Bullosa
Almirall SA
0
catalysts
ALOCRIL
ALOCRIL (NEDOCROMIL SODIUM)
ALLERGAN
0
catalysts
ALOGLIPTIN AND PIOGLITAZONE
ALOGLIPTIN AND PIOGLITAZONE (ALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDE)
TAKEDA PHARMS USA
0
catalysts
Phase 1
ALX-001
Alzheimer's Disease
Allyx Therapeutics Inc
0
catalysts
Phase 1
ALX-1
Bronchiectasis
Parathyroid hormone/parathyroid hormone-related peptide receptor
Vast Therapeutics Inc
0
catalysts
Phase 1
ALX-2004
Colorectal Cancer
$ALXO
ALX ONCOLOGY HOLDINGS INC
0
catalysts
Phase 2
ALY-101
Alopecia Areata
Alys Pharmaceuticals Inc
0
catalysts
Preclinical
ALY-732
Duchenne Muscular Dystrophy
Allysta Pharmaceuticals Inc
0
catalysts
ALYACEN 7/7/7
ALYACEN 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)
GLENMARK PHARMS LTD
0
catalysts
ALYFTREK
ALYFTREK (DEUTIVACAFTOR)
1 INDICATIONS AND USAGE ALYFTREK is indicated for the treatment of cystic fib…
Cystic fibrosis transmembrane conductance regulator
$VERX
Vertex, Inc.
0
catalysts
Preclinical
AM-1101
Osteoarthritis
Amplicore Inc
0
catalysts
Phase 2
AM-3101
Unspecified Musculoskeletal Disorders
Amplicore Inc
0
catalysts
Preclinical
AM-401
Colorectal Cancer
$CYTOF
Altamira Therapeutics Ltd.
0
catalysts
Preclinical
AM-805
Alzheimer's Disease
Amlogenyx
0
catalysts
